University of Oulu

Mäki-Opas, I., Hämäläinen, M., Moilanen, L. J., Sood, H., Leppänen, T., Kummola, L., Junttila, I. S., Lehtimäki, L., & Moilanen, E. (2023). Trpa1 mediates contact hypersensitivity induced by 2,4-dinitrochlorobenzene. Journal of Investigative Dermatology, 143(6), 1104-1108.e4. https://doi.org/10.1016/j.jid.2022.12.014

TRPA1 mediates contact hypersensitivity induced by 2,4-dinitrochlorobenzene

Saved in:
Author: Mäki-Opas, Ilari1; Hämäläinen, Mari1; Moilanen, Lauri J.1;
Organizations: 1The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland
2Biodiversity Interventions for Well-being, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
3Cytokine Biology Research Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
4Fimlab Laboratories, Tampere, Finland
5Northern Finland Laboratory Centre (NordLab), Oulu, Finland
6Research Unit of Biomedicine, Faculty of Medicine, University of Oulu, Oulu, Finland
7Allergy Centre, Tampere University Hospital, Tampere, Finland
8Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
Format: article
Version: published version
Access: open
Online Access: PDF Full Text (PDF, 1 MB)
Persistent link: http://urn.fi/urn:nbn:fi-fe20230823103509
Language: English
Published: Elsevier, 2023
Publish Date: 2023-08-23
Series: Journal of investigative dermatology
ISSN: 0022-202X
ISSN-E: 1523-1747
ISSN-L: 0022-202X
Volume: 143
Issue: 6
Pages: 1104 - 1108.e4
DOI: 10.1016/j.jid.2022.12.014
OADOI: https://oadoi.org/10.1016/j.jid.2022.12.014
Type of Publication: A1 Journal article – refereed
Field of Science: 3121 General medicine, internal medicine and other clinical medicine
Subjects:
Funding: This study was supported by grants from The Academy of Finland (EM) and Tampere Tuberculosis Foundation (EM) and by competitive research funding (VTR funding) from Tampere University Hospital (EM). ISJ is supported by the Academy of Finland (grants 25013080481 and 25013142041), The Competitive State Research Financing of the Expert Responsibility Area of Fimlab Laboratories (grant X51409), Tampere University Hospital Support Foundation (grant MK247), Tampere Tuberculosis Foundation and Nordlab Laboratories (grant X3710-KT0011).
Copyright information: © 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
  https://creativecommons.org/licenses/by/4.0/